【作者】 吴仲起；

【导师】 马静；

【作者基本信息】 南京航空航天大学 ， 产业经济学， 2006， 硕士

【摘要】 改革开放以来,我国医药制造业取得了长足的发展,其生产和市场规模都获得了高速增长。但是,其在产值高速增长的情况下却少有自主创新,这种状况对行业的持续健康发展甚为不利。本文即试图运用技术创新及产业经济学的相关理论,对我国制药业的现状及存在的技术创新乏力问题作出分析,并进行对策研究。我国目前对制药业的技术创新研究,主要集中在分析企业创新投入少、创新人才缺乏等导致其技术创新乏力的直接原因上,对其在产业组织方面的问题等根本原因缺乏深入研究。本文研究认为,世界制药业的迅猛发展一方面得益于世界医药市场需求的不断扩大,更重要的一方面得益于其强劲的技术创新和研发能力。从全球范围来看,医药制造业已经是名副其实的技术创新驱动型产业。而我国制药业的高速增长主要得益于国内市场需求的扩张,是一种典型的规模扩张型的发展模式。在运用索洛余值法对我国制药业经济增长中技术进步作用进行了定量测算,并对测算结果进行了分析之后,本文得出结论认为其是一个技术创新乏力的行业。接下来,论文运用相关技术创新理论及产业组织理论等,对我国制药业技术创新乏力的根本原因进行了深入分析,主要集中在产业组织、基础研究等方面的原因分析。针对我国制药业技术创新乏力的根本原因,文章最后从政府和企业两个角度提出了提高技术创新能力的对策,主要集中于政府的产业组织政策及企业的激励创新措施研究。更多还原

【Abstract】 Since the beginning of reform and opening up, China’s pharmaceutical industry has been considerably developed. It has got high-speed growth of manufacture and marketing. However, China’s pharmaceutical industry has few innovations.Such a situation is detrimental to the healthy development of China’s pharmaceutical industry. This paper is an attempt to analyse the present situation and problems of weak technological innovation of China’s pharmaceutical industry by using the theory of technological innovation and industrial economics, and propose countermeasures.China’s current study of the pharmaceutical industry focus on the direct reasons of weakness of technological innovation ,such as less capital investment and lack of creative talents. But there is a lake of in-depth study in its underlying causes of the problems that exist in the industrial organization .The paper researches the development status and characteristics of the global pharmaceutical industry, argues that, on one hand, the rapid development of the global pharmaceutical industry benefits from the continued expansion of world pharmaceutical market needs,on the other hand, it benefits from the strong investment in R & D and technological innovation. World pharmaceutical industry is a real technical innovation-driven manufacturing industries. But,the rapid growth of China’s pharmaceutical industry was largely attributed to the expansion of domestic demand. It is a typical example of the expansion of scale-model of development.The paper use Solow residual value method to calculate the technological progress role in China’s pharmaceutical industry economic growth . Calculation results are also analyzed. China’s pharmaceutical industry is a weak technical innovation industries.Then,the paper use technology innovation theory and industrial organization theory to analyse the root causes of weak technological innovation in China’s pharmaceutical industry, mainly concentrated in industrial organization, basic research and other causes.The thesis amid the root causes of weak technological innovation in the pharmaceutical industry, propose governments and enterprises measures to enhance the ability in technological innovation. The proposal focused on the government’s policies on industrial organization and corporate policies encouraging innovation.更多还原